Greg Cohen

434 total citations
10 papers, 370 citations indexed

About

Greg Cohen is a scholar working on Pathology and Forensic Medicine, Oncology and Surgery. According to data from OpenAlex, Greg Cohen has authored 10 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Greg Cohen's work include Genetic factors in colorectal cancer (4 papers), Inflammatory mediators and NSAID effects (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Greg Cohen is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), Inflammatory mediators and NSAID effects (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Greg Cohen collaborates with scholars based in United States, Canada and United Kingdom. Greg Cohen's co-authors include Loren Joseph, Marc Bissonnette, Sharad Khare, Chris J. Norbury, Howard O. Fearnhead, Marion MacFarlane, John Hart, Ramesh K. Wali, Sandra Cerda and Urszula Dougherty and has published in prestigious journals such as Gastroenterology, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Greg Cohen

10 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Greg Cohen United States 7 193 177 73 59 58 10 370
Laurie P. Peiffer United States 12 133 0.7× 160 0.9× 96 1.3× 69 1.2× 61 1.1× 24 436
Vorapan Sirivatanauksorn Thailand 13 114 0.6× 181 1.0× 43 0.6× 33 0.6× 37 0.6× 16 364
Kuei‐Li Lin Taiwan 13 60 0.3× 185 1.0× 45 0.6× 36 0.6× 62 1.1× 23 421
H Ohmori Japan 8 114 0.6× 252 1.4× 105 1.4× 37 0.6× 21 0.4× 12 481
Sang Hyun Song South Korea 10 82 0.4× 242 1.4× 47 0.6× 35 0.6× 55 0.9× 22 396
Anna Junjie Shangguan China 8 134 0.7× 176 1.0× 22 0.3× 26 0.4× 94 1.6× 12 403
Nilesh Kashikar United States 8 181 0.9× 246 1.4× 44 0.6× 60 1.0× 24 0.4× 8 424
Yuqing Wang China 8 76 0.4× 146 0.8× 90 1.2× 21 0.4× 37 0.6× 21 402
Shiann Pan Taiwan 11 48 0.2× 122 0.7× 99 1.4× 27 0.5× 28 0.5× 25 309

Countries citing papers authored by Greg Cohen

Since Specialization
Citations

This map shows the geographic impact of Greg Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Cohen more than expected).

Fields of papers citing papers by Greg Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Greg Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Cohen. The network helps show where Greg Cohen may publish in the future.

Co-authorship network of co-authors of Greg Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Greg Cohen. A scholar is included among the top collaborators of Greg Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Greg Cohen. Greg Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pekow, Joel, Urszula Dougherty, Yong Huang, et al.. (2013). Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions. Inflammatory Bowel Diseases. 19(3). 461–470. 39 indexed citations
2.
Khare, Sharad, Reba Mustafi, Sandra Cerda, et al.. (2008). Ursodeoxycholic Acid Suppresses Cox-2 Expression in Colon Cancer: Roles of Ras, p38, and CCAAT/Enhancer-Binding Protein. Nutrition and Cancer. 60(3). 389–400. 44 indexed citations
3.
Fichera, Alessandro, Sujatha Jagadeeswaran, Urszula Dougherty, et al.. (2007). Epidermal Growth Factor Receptor Signaling Is Required for Microadenoma Formation in the Mouse Azoxymethane Model of Colonic Carcinogenesis. Cancer Research. 67(2). 827–835. 47 indexed citations
4.
Cohen, Greg, Reba Mustafi, Sandra Cerda, et al.. (2006). Epidermal Growth Factor Receptor Signaling Is Up-regulated in Human Colonic Aberrant Crypt Foci. Cancer Research. 66(11). 5656–5664. 45 indexed citations
5.
Cohen, Greg, Maria Tretiakova, Robert E. Carroll, & Marc Bissonnette. (2003). COX-2 and iNOS are overexpressed in human colonic aberrant crypt foci. Gastroenterology. 124(4). A605–A605. 1 indexed citations
6.
Khare, Sharad, Sandra Cerda, Ramesh K. Wali, et al.. (2003). Ursodeoxycholic acid inhibits Ras mutations, wild-type Ras activation, and cyclooxygenase-2 expression in colon cancer.. PubMed. 63(13). 3517–23. 52 indexed citations
7.
Wali, Ramesh K., Sharad Khare, Maria Tretiakova, et al.. (2002). Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer. Cancer Epidemiology and Prevention Biomarkers. 11(12). 1653–1662. 2 indexed citations
8.
Wali, Ramesh K., Sharad Khare, Maria Tretiakova, et al.. (2002). Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.. PubMed. 11(12). 1653–62. 75 indexed citations
9.
Cohen, Greg, et al.. (1999). Caspases and apoptosis. European Journal of Cancer. 35. S307–S307. 3 indexed citations
10.
Norbury, Chris J., Marion MacFarlane, Howard O. Fearnhead, & Greg Cohen. (1994). CDC2 Activation Is Not Required for Thymocyte Apoptosis. Biochemical and Biophysical Research Communications. 202(3). 1400–1406. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026